- In February 2024, Varian Medical Systems, Inc. obtained FDA 510(k) clearance for its TrueBeam and Edge radiotherapy systems, now incorporating the HyperSight imaging solution. This approval enables the company to enhance imaging capabilities within the radiotherapy treatment room, significantly improving the precision of cancer treatments. By integrating this advanced imaging technology, Varian aims to strengthen its market presence and offer superior solutions to healthcare providers in oncology
- In May 2023, STERIS announced the establishment of a new electron beam processing facility in Biassono, Italy, underscoring its commitment to enhancing medical device manufacturing. This facility will expand the company’s electron beam processing capacity, allowing for improved sterilization and treatment of medical products. By investing in this state-of-the-art facility, STERIS aims to strengthen its position in the market and better meet the growing demand for high-quality medical devices
- In October 2023, Washington State University announced the installation of a cutting-edge linear accelerator, marking a significant advancement in cancer treatment technology. This new equipment will provide enhanced radiation therapy and essential treatments specifically for animal cancer patients at the Veterinary Teaching Hospital. This development underscores the institution's commitment to improving veterinary care and expanding treatment options for pets facing cancer
- In October 2022, the Raja Ramanna Centre for Advanced Technology revealed a partnership with a Mumbai-based company to incubate an electron linear accelerator (Linac) designed for sterilizing medical devices. This collaboration aims to develop advanced technology that enhances the safety and efficacy of medical sterilization processes. By focusing on innovative solutions, the initiative highlights the commitment to improving healthcare standards and ensuring the availability of safe medical products
